These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 6480799)

  • 1. Urinary molecular forms of human N-terminal of proopiomelanocortin: possible deglycosylation and degradation by the kidney.
    Gaspar L; Chan JS; Seidah NG; Chrétien M
    J Clin Endocrinol Metab; 1984 Oct; 59(4):614-21. PubMed ID: 6480799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of N-terminal fragment of proopiomelanocortin in cerebrospinal fluid.
    Gaspar L; Chan JS; Seidah NG; Chrétien M
    J Clin Endocrinol Metab; 1987 Jul; 65(1):198-202. PubMed ID: 3584397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peptides related to the N-terminus of pro-opiomelanocortin in the human adrenal medulla.
    Gaspar L; Chan JS; Seidah NG; Chrétien M
    Clin Invest Med; 1989 Apr; 12(2):90-8. PubMed ID: 2539931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of peptides derived from pro-opiomelanocortin in the biological fluids of a patient with Nelson's syndrome.
    Gaspar L; Chan JS; Seidah NG; Chrétien M
    Clin Invest Med; 1985; 8(2):167-75. PubMed ID: 3009068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary levels of immunoreactive NH2-terminal of pro-opiomelanocortin in patients with malignant pulmonary disease.
    Gaspar L; Gilbert F; Chan JS; Seidah NG; Chrétien M
    Clin Invest Med; 1989 Aug; 12(4):241-6. PubMed ID: 2535437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha-amidated peptides derived from pro-opiomelanocortin in human pituitary tumours.
    Fenger M; Johnsen AH
    J Endocrinol; 1988 Aug; 118(2):329-38. PubMed ID: 2844950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pro-gamma-MSH levels in various disorders of pituitary-adrenal axis.
    Boscaro M; Giacomazzi P; Sonino N; Fallo F; Girard F; Bertagna X; Mantero F
    J Endocrinol Invest; 1990 Jan; 13(1):29-33. PubMed ID: 2156920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human NH2 terminal of pro-opiomelanocortin as a potential marker for pulmonary carcinoma.
    Chan JS; Seidah NG; Chrétien M
    Cancer Res; 1983 Jul; 43(7):3066-9. PubMed ID: 6303575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic clearance rate and half-time disappearance rate of human N-terminal and adrenocorticotropin of pro-opiomelanocortin in the rat: a comparative study.
    Lu CL; Chan JS; De Léan A; Chen A; Seidah NG; Chrétien M
    Life Sci; 1983 Dec; 33(26):2599-608. PubMed ID: 6319844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human plasma proopiomelanocortin N-terminal peptide and adrenocorticotropin: circadian rhythm, dexamethasone suppression, and corticotropin-releasing hormone stimulation.
    Motomatsu T; Takahashi H; Ibayashi H; Nobunaga M
    J Clin Endocrinol Metab; 1984 Sep; 59(3):495-8. PubMed ID: 6086700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peptides related to the NH2-terminal end of proopiocortin in man.
    Bertagna X; Seurin D; Pique L; Luton JP; Bricaire H; Girard F
    J Clin Endocrinol Metab; 1983 Mar; 56(3):489-95. PubMed ID: 6822650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of pro-opiomelanocortin-derived peptides in pituitary and ectopic adrenocorticotrophin-secreting tumours.
    Hale AC; Besser GM; Rees LH
    J Endocrinol; 1986 Jan; 108(1):49-56. PubMed ID: 3003221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High molecular weight forms of human ACTH are glycoproteins.
    Orth DN; Nicholson WE
    J Clin Endocrinol Metab; 1977 Jan; 44(1):214-7. PubMed ID: 188860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma immunoreactive joining peptide in man: a new marker of proopiomelanocortin processing and corticotroph function.
    Phlipponneau M; Lenne F; Proeschel MF; Girard F; Luton JP; Bertagna X
    J Clin Endocrinol Metab; 1993 Feb; 76(2):325-9. PubMed ID: 8381797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human joining peptide: a proopiomelanocortin product secreted as a homodimer.
    Bertagna X; Camus F; Lenne F; Girard F; Luton JP
    Mol Endocrinol; 1988 Nov; 2(11):1108-14. PubMed ID: 3221877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of the NH2-terminal portion of pro-opiomelanocortin as a biomarker for human lung cancer.
    Gilbert F; Walop W; Chan JS; Benjannet S; Seidah NG; Spitzer WO; Chrétien M
    Clin Invest Med; 1987 Sep; 10(5):372-6. PubMed ID: 2824112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoreactive proopiomelanocortin (POMC) peptides and POMC-like messenger ribonucleic acid are present in many rat nonpituitary tissues.
    DeBold CR; Nicholson WE; Orth DN
    Endocrinology; 1988 Jun; 122(6):2648-57. PubMed ID: 2836169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proopiolipomelanocortin peptides in normal pituitary, pituitary tumor, and plasma of normal and Cushing's horses.
    Wilson MG; Nicholson WE; Holscher MA; Sherrell BJ; Mount CD; Orth DN
    Endocrinology; 1982 Mar; 110(3):941-54. PubMed ID: 6276164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoreactive gamma-melanotropin in rat pituitary and plasma: a partial characterization.
    Pedersen RC; Ling N; Brownie AC
    Endocrinology; 1982 Mar; 110(3):825-34. PubMed ID: 6276159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peptides related to alpha-melanocyte-stimulating hormone are commonly produced by human pituitary corticotroph adenomas: no relationship with pars intermedia origin.
    Coates PJ; Doniach I; Wells C; Hale AC; Rees LH; Besser GM
    J Endocrinol; 1989 Mar; 120(3):531-6. PubMed ID: 2538539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.